Gene Selection for the Discrimination of Colorectal Cancer.
暂无分享,去创建一个
Wenhui Wang | Guanglei Xie | Zhonglu Ren | Tingyan Xie | Jinming Li | Zhonglu Ren | Wen-Hui Wang | Jinming Li | T. Xie | Guanglei Xie
[1] S. Pileri,et al. Relationship between Dyskerin Expression and Telomerase Activity in Human Breast Cancer , 2008, Cellular oncology : the official journal of the International Society for Cellular Oncology.
[2] Mira Ayadi,et al. Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value , 2013, PLoS medicine.
[3] Somatic mutations of amino acid metabolism-related genes in gastric and colorectal cancers and their regional heterogeneity - a short report , 2014, Cellular Oncology.
[4] Zhaoqing Yang,et al. IL-6 Inhibits the Targeted Modulation of PDCD4 by miR-21 in Prostate Cancer , 2015, PloS one.
[5] Y. Adachi,et al. Neurotransmitter Transporter Family Including SLC6A6 and SLC6A13 Contributes to the 5‐Aminolevulinic Acid (ALA)‐Induced Accumulation of Protoporphyrin IX and Photodamage, through Uptake of ALA by Cancerous Cells , 2014, Photochemistry and photobiology.
[6] Xiangjiao Meng,et al. PDCD4 as a predictor of sensitivity to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients. , 2014, Asian Pacific journal of cancer prevention : APJCP.
[7] R Engers,et al. DKC1 overexpression associated with prostate cancer progression , 2009, British Journal of Cancer.
[8] Yong Xu,et al. RPCA-Based Tumor Classification Using Gene Expression Data , 2015, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[9] B. Wiedenmann,et al. Activin A stimulates vascular endothelial growth factor gene transcription in human hepatocellular carcinoma cells. , 2004, Gastroenterology.
[10] S. Tomida,et al. KIAA1199 interacts with glycogen phosphorylase kinase β-subunit (PHKB) to promote glycogen breakdown and cancer cell survival , 2014, Oncotarget.
[11] F. Petraglia,et al. Activin, inhibin and the human breast , 2004, Molecular and Cellular Endocrinology.
[12] G. G. Van den Eynden,et al. P‐cadherin in adhesion and invasion: Opposite roles in colon and bladder carcinoma , 2011, International journal of cancer.
[13] H. Tsuda,et al. Reduced Expression of GNA11 and Silencing of MCT1 in Human Breast Cancers , 2003, Oncology.
[14] C. S. St. Hill,et al. C2-O-sLeX Glycoproteins Are E-Selectin Ligands that Regulate Invasion of Human Colon and Hepatic Carcinoma Cells , 2011, PloS one.
[15] K. Shroyer,et al. Hypoxia promotes colon cancer dissemination through up-regulation of cell migration-inducing protein (CEMIP) , 2015, Oncotarget.
[16] Li-Yeh Chuang,et al. Improved binary PSO for feature selection using gene expression data , 2008, Comput. Biol. Chem..
[17] Jianfeng Jin,et al. MicroRNA-107: a novel promoter of tumor progression that targets the CPEB3/EGFR axis in human hepatocellular carcinoma , 2015, Oncotarget.
[18] J. Scheller,et al. The IL-6/sIL-6R complex as a novel target for therapeutic approaches , 2007, Expert opinion on therapeutic targets.
[19] Lixin Sun,et al. P-cadherin promotes liver metastasis and is associated with poor prognosis in colon cancer. , 2011, The American journal of pathology.
[20] Y. Nakamura,et al. Overexpressing PKIB in prostate cancer promotes its aggressiveness by linking between PKA and Akt pathways , 2009, Oncogene.
[21] B. Dickson,et al. Familial pheochromocytoma and renal cell carcinoma syndrome: TMEM127 as a novel candidate gene for the association , 2015, Virchows Archiv.
[22] Antonio J. Nebro,et al. Molecular Docking Optimization in the Context of Multi-Drug Resistant and Sensitive EGFR Mutants , 2016, Molecules.
[23] W. Jiang,et al. KIAA1199 and its biological role in human cancer and cancer cells (review). , 2014, Oncology reports.
[24] K. Mimori,et al. Significance of INHBA expression in human colorectal cancer. , 2013, Oncology reports.
[25] Masato Terashima,et al. Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer. , 2015, Cancer letters.
[26] Y. Matsumura,et al. Role of SLC6A6 in promoting the survival and multidrug resistance of colorectal cancer , 2014, Scientific Reports.
[27] P. Vivas-Mejia,et al. Upregulation of miR-21 in Cisplatin Resistant Ovarian Cancer via JNK-1/c-Jun Pathway , 2014, PloS one.
[28] W. Ahn,et al. An 8-gene signature, including methylated and down-regulated glutathione peroxidase 3, of gastric cancer. , 2009, International journal of oncology.
[29] D. Lodygin,et al. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis. , 2014, The Journal of clinical investigation.
[30] H. Nemoto,et al. Frequent CDH3 demethylation in advanced gastric carcinoma. , 2009, Anticancer research.
[31] Wengang Zhou,et al. A novel class dependent feature selection method for cancer biomarker discovery , 2014, Comput. Biol. Medicine.
[32] G. Seki,et al. Localization of NBC-1 variants in human kidney and renal cell carcinoma. , 2003, Biochemical and biophysical research communications.
[33] A. Oberg,et al. Highly Methylated Genes in Colorectal Neoplasia: Implications for Screening , 2007, Cancer Epidemiology Biomarkers & Prevention.
[34] P. Sadłecki,et al. Serum Inhibin A and Inhibin B Levels in Epithelial Ovarian Cancer Patients , 2014, PloS one.
[35] Maode Lai,et al. Identification of differentially expressed proteins in colorectal cancer by proteomics: Down‐regulation of secretagogin , 2006, Proteomics.
[36] K. Lawson,et al. P-cadherin potentiates ligand-dependent EGFR and IGF-1R signaling in dysplastic and malignant oral keratinocytes. , 2014, Oncology reports.
[37] A. Tejerina,et al. Relationship between Genotypes Sult1a2 and Cyp2d6 and Tamoxifen Metabolism in Breast Cancer Patients , 2013, PloS one.
[38] M. Furia,et al. Real-time PCR quantification of human DKC1 expression in colorectal cancer , 2008, Acta oncologica.
[39] Michael Krawczak,et al. Genome-wide association study for colorectal cancer identifies risk polymorphisms in German familial cases and implicates MAPK signalling pathways in disease susceptibility. , 2010, Carcinogenesis.
[40] Wei Xie,et al. Accurate Cancer Classification Using Expressions of Very Few Genes , 2007, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[41] Taghi M. Khoshgoftaar,et al. RUSBoost: A Hybrid Approach to Alleviating Class Imbalance , 2010, IEEE Transactions on Systems, Man, and Cybernetics - Part A: Systems and Humans.
[42] Jie Liu,et al. miR-183 induces cell proliferation, migration, and invasion by regulating PDCD4 expression in the SW1990 pancreatic cancer cell line. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[43] Hala Alshamlan,et al. mRMR-ABC: A Hybrid Gene Selection Algorithm for Cancer Classification Using Microarray Gene Expression Profiling , 2015, BioMed research international.
[44] Anirban Mukherjee,et al. Cancer Classification from Gene Expression Data by NPPC Ensemble , 2011, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[45] R. Seruca,et al. CCAAT/Enhancer Binding Protein β (C/EBPβ) Isoforms as Transcriptional Regulators of the Pro-Invasive CDH3/P-Cadherin Gene in Human Breast Cancer Cells , 2013, PloS one.
[46] Nitesh V. Chawla,et al. SMOTEBoost: Improving Prediction of the Minority Class in Boosting , 2003, PKDD.
[47] Rami N. Khushaba,et al. Feature subset selection using differential evolution and a wheel based search strategy , 2013, Swarm Evol. Comput..
[48] L. Wȩglarz,et al. Transcriptional regulation of interleukin 6 and its receptor in colon cancer cells by phytic acid. , 2010, Acta poloniae pharmaceutica.
[49] Daniel Heim,et al. Copy number changes of clinically actionable genes in melanoma, non‐small cell lung cancer and colorectal cancer—A survey across 822 routine diagnostic cases , 2016, Genes, chromosomes & cancer.
[50] N Chawla,et al. SMOTEBoost:ブースティングにおけるマイノリティクラスの予測改善(原標題は英語) , 2003 .
[51] Joobae Park,et al. Association of interindividual differences in p14ARF promoter methylation with single nucleotide polymorphism in primary colorectal cancer , 2008, Cancer.
[52] Jan Komorowski,et al. BIOINFORMATICS ORIGINAL PAPER doi:10.1093/bioinformatics/btm486 Data and text mining Monte Carlo , 2022 .
[53] A. Koong,et al. Epigenetic Regulation of Gene Expression in Cervical Cancer Cells by the Tumor Microenvironment 1 , 2000 .
[54] Hui Liu,et al. Dyskerin Overexpression in Human Hepatocellular Carcinoma Is Associated with Advanced Clinical Stage and Poor Patient Prognosis , 2012, PloS one.
[55] H. Allgayer,et al. Loss of programmed cell death 4 expression marks adenoma‐carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer , 2007, Cancer.
[56] G. Ryffel,et al. HNF4α reduces proliferation of kidney cells and affects genes deregulated in renal cell carcinoma , 2005, Oncogene.
[57] Yanqin Sun,et al. Overexpression of secretagogin inhibits cell apoptosis and induces chemoresistance in small cell lung cancer under the regulation of miR-494 , 2014, Oncotarget.
[58] Steven S. Chang,et al. Inactivation of the Tumor Suppressor Genes Causing the Hereditary Syndromes Predisposing to Head and Neck Cancer via Promoter Hypermethylation in Sporadic Head and Neck Cancers , 2010, ORL.
[59] M. Suiko,et al. Sulfation of benzyl alcohol by the human cytosolic sulfotransferases (SULTs): a systematic analysis , 2016, Journal of applied toxicology : JAT.
[60] S. Ingvarsson,et al. MicroRNA-451 suppresses tumor cell growth by down-regulating IL6R gene expression. , 2014, Cancer epidemiology.
[61] Chen Jiang,et al. Genomic profiling in locally advanced and inflammatory breast cancer and its link to DCE-MRI and overall survival , 2015, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[62] PKIB expression strongly correlated with phosphorylated Akt expression in breast cancers and also with triple-negative breast cancer subtype , 2012, Medical Molecular Morphology.
[63] K. Kelsey,et al. Interaction between the bone morphogenetic proteins and Ras/MAP-kinase signalling pathways in lung cancer , 2005, British Journal of Cancer.
[64] Zhen Ji,et al. Iterative ensemble feature selection for multiclass classification of imbalanced microarray data , 2016, Journal of Biological Research-Thessaloniki.
[65] Anne-Mette K. Hein,et al. Alternative Splicing in Colon, Bladder, and Prostate Cancer Identified by Exon Array Analysis*S , 2008, Molecular & Cellular Proteomics.
[66] Jason Weston,et al. Gene Selection for Cancer Classification using Support Vector Machines , 2002, Machine Learning.
[67] J. Hackermüller,et al. CD31, EDNRB and TSPAN7 are promising prognostic markers in clear‐cell renal cell carcinoma revealed by genome‐wide expression analyses of primary tumors and metastases , 2012, International journal of cancer.
[68] A Min Tjoa,et al. Performance Comparison between Naïve Bayes, Decision Tree and k-Nearest Neighbor in Searching Alternative Design in an Energy Simulation Tool , 2013 .
[69] L. Fliegel,et al. Defining the Na+/H+ exchanger NHE1 interactome in triple-negative breast cancer cells. , 2017, Cellular signalling.
[70] J. Souverijn,et al. Multitarget stool DNA testing for colorectal-cancer screening. , 2014, The New England journal of medicine.
[71] Yusuke Nakamura,et al. Identification of a Novel Tumor-Associated Antigen, Cadherin 3/P-Cadherin, as a Possible Target for Immunotherapy of Pancreatic, Gastric, and Colorectal Cancers , 2008, Clinical Cancer Research.
[72] Erik D. Goodman,et al. Swarmed feature selection , 2004, 33rd Applied Imagery Pattern Recognition Workshop (AIPR'04).
[73] H. Allgayer. Pdcd4, a colon cancer prognostic that is regulated by a microRNA. , 2007, Critical reviews in oncology/hematology.
[74] R. Russell,et al. Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia. , 1992, British Journal of Cancer.
[75] N. Miller,et al. MicroRNA-21 and PDCD4 expression in colorectal cancer. , 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[76] Jill S Barnholtz-Sloan,et al. Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survival , 2015, Oncotarget.
[77] Yate-Ching Yuan,et al. Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer , 2015, Breast Cancer Research and Treatment.
[78] T. Matsuda,et al. Bystin in human cancer cells: intracellular localization and function in ribosome biogenesis. , 2007, The Biochemical journal.
[79] I. Pastan,et al. Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells. , 1990, Cancer research.
[80] Z. Ye,et al. Role of BMP3 in progression of gastric carcinoma in Chinese people. , 2010, World journal of gastroenterology.
[81] Jing-he Li,et al. N-cadherin and P-cadherin are biomarkers for invasion, metastasis, and poor prognosis of gallbladder carcinomas. , 2014, Pathology, research and practice.
[82] T. Dingermann,et al. An Interstitial Deletion at 3p21.3 Results in the Genetic Fusion of MLH1 and ITGA9 in a Lynch Syndrome Family , 2009, Clinical Cancer Research.
[83] Liviu Badea,et al. Identification of potential biomarkers for early and advanced gastric adenocarcinoma detection. , 2010, Hepato-gastroenterology.
[84] André F. Vieira,et al. The basal epithelial marker P-cadherin associates with breast cancer cell populations harboring a glycolytic and acid-resistant phenotype , 2014, BMC Cancer.
[85] E. Sauter,et al. Increased shedding of soluble fragments of P‐cadherin in nipple aspirate fluids from women with breast cancer , 2008, Cancer science.
[86] H. Bhat,et al. Natural Antioxidants Exhibit Chemopreventive Characteristics through the Regulation of CNC b‐Zip Transcription Factors in Estrogen‐Induced Breast Carcinogenesis , 2014, Journal of biochemical and molecular toxicology.
[87] Byung Ro Moon,et al. Hybrid Genetic Algorithms for Feature Selection , 2004, IEEE Trans. Pattern Anal. Mach. Intell..
[88] B. Minsky. Unique considerations in the patient with rectal cancer. , 2011, Seminars in oncology.
[89] B. Li,et al. miR-150 Modulates Cisplatin Chemosensitivity and Invasiveness of Muscle-Invasive Bladder Cancer Cells via Targeting PDCD4 In Vitro , 2014, Medical science monitor : international medical journal of experimental and clinical research.
[90] Shiquan Sun,et al. A Kernel-Based Multivariate Feature Selection Method for Microarray Data Classification , 2014, PloS one.
[91] Namita Srivastava,et al. A fuzzy based feature selection from independent component subspace for machine learning classification of microarray data , 2016, Genomics data.
[92] Q. Zou,et al. Hierarchical Classification of Protein Folds Using a Novel Ensemble Classifier , 2013, PloS one.
[93] C. Mathers,et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.
[94] L. Crinò,et al. DKC1 gene mutations in human sporadic cancer. , 2013, Histology and histopathology.
[95] Xin Huang,et al. Functional proteomic analysis reveals the involvement of KIAA1199 in breast cancer growth, motility and invasiveness , 2014, BMC Cancer.
[96] Adel Al-Jumaily,et al. Differential evolution based feature subset selection , 2008, 2008 19th International Conference on Pattern Recognition.
[97] Hua-mei Tang,et al. Screening of new tumor suppressor genes in sporadic colorectal cancer patients. , 2008, Hepato-gastroenterology.
[98] C. Hellerbrand,et al. Downregulation of P-cadherin expression in hepatocellular carcinoma induces tumorigenicity. , 2013, International journal of clinical and experimental pathology.
[99] Y. Li,et al. Specific N-glycans of Hepatocellular Carcinoma Cell Surface and the Abnormal Increase of Core-α-1, 6-fucosylated Triantennary Glycan via N-acetylglucosaminyltransferases-IVa Regulation , 2015, Scientific Reports.
[100] J. Ko,et al. Overexpression and β-1,6-N-Acetylglucosaminylation-initiated Aberrant Glycosylation of TIMP-1 , 2012, The Journal of Biological Chemistry.
[101] Karen A Gelmon,et al. P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer , 2011, Modern Pathology.
[102] Toshiaki Watanabe,et al. Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients. , 2012, Oncology reports.
[103] V. Prasolov,et al. Altered Expression of Multiple Genes Involved in Retinoic Acid Biosynthesis in Human Colorectal Cancer , 2014, Pathology & Oncology Research.
[104] W. Isaacs,et al. P-Cadherin is a basal cell-specific epithelial marker that is not expressed in prostate cancer. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[105] Xudong Wang,et al. Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer. , 2015, International journal of clinical and experimental pathology.
[106] Xi-shun Cheng,et al. Hypermethylation and Expression Silencing of PDCD4 Gene in Hepatocellular Carcinoma , 2016, Medicine.
[107] J. Jessurun,et al. The high affinity selectin glycan ligand C2-O-sLex and mRNA transcripts of the core 2 β-1,6-N-acetylglusaminyltransferase (C2GnT1) gene are highly expressed in human colorectal adenocarcinomas , 2009, BMC Cancer.
[108] Chang-Yi Hsieh,et al. Activin A Enhances Prostate Cancer Cell Migration Through Activation of Androgen Receptor and Is Overexpressed in Metastatic Prostate Cancer , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[109] I. Csabai,et al. Aberrant DNA methylation of WNT pathway genes in the development and progression of CIMP-negative colorectal cancer , 2016, Epigenetics.
[110] J. Pouysségur,et al. The Na+/HCO3− Co‐Transporter SLC4A4 Plays a Role in Growth and Migration of Colon and Breast Cancer Cells , 2015, Journal of cellular physiology.
[111] Yun Chen,et al. Regulation of the Expression of Cytoplasmic Polyadenylation Element Binding Proteins for the Treatment of Cancer. , 2016, Anticancer research.
[112] P. Conesa‐Zamora,et al. Immunohistochemical expression profile of β-catenin, E-cadherin, P-cadherin, laminin-5γ2 chain, and SMAD4 in colorectal serrated adenocarcinoma. , 2012, Human pathology.
[113] M. Cairns,et al. Regulation of the tumour suppressor PDCD4 by miR-499 and miR-21 in oropharyngeal cancers , 2016, BMC Cancer.
[114] S. Wakabayashi,et al. Crystallization and preliminary crystallographic analysis of the human calcineurin homologous protein CHP2 bound to the cytoplasmic region of the Na+/H+ exchanger NHE1. , 2005, Acta crystallographica. Section F, Structural biology and crystallization communications.
[115] Wenfu Wang,et al. Helicobacter pylori Promotes Epithelial–Mesenchymal Transition in Gastric Cancer by Downregulating Programmed Cell Death Protein 4 (PDCD4) , 2014, PloS one.
[116] W. Fang,et al. Reduced PDCD4 Expression Promotes Cell Growth Through PI3K/Akt Signaling in Non-Small Cell Lung Cancer , 2016, Oncology research.
[117] R. Domingues,et al. Coexistence of paraganglioma/pheochromocytoma and papillary thyroid carcinoma: a four-case series analysis , 2015, Familial Cancer.
[118] D. Latchman,et al. Identification and characterization of the promoter region of the Nav1.7 voltage-gated sodium channel gene (SCN9A) , 2008, Molecular and Cellular Neuroscience.
[119] T. Campbell,et al. Functional expression of the voltage-gated Na+-channel Nav1.7 is necessary for EGF-mediated invasion in human non-small cell lung cancer cells , 2013, Journal of Cell Science.
[120] S. Srikantan,et al. The tumor susceptibility gene TMEM127 is mutated in renal cell carcinomas and modulates endolysosomal function. , 2014, Human molecular genetics.
[121] Li Lin,et al. Voltage‐gated sodium channel Nav1.7 promotes gastric cancer progression through MACC1‐mediated upregulation of NHE1 , 2016, International journal of cancer.
[122] N. Cho,et al. Panel of candidate biomarkers for renal cell carcinoma. , 2010, Journal of proteome research.
[123] G. Chen,et al. Concomitant high expression of BRAFV600E, P‐cadherin and cadherin 6 is associated with High TNM stage and lymph node metastasis in conventional papillary thyroid carcinoma , 2016, Clinical endocrinology.
[124] W. El-Rifai,et al. Activin a signaling regulates cell invasion and proliferation in esophageal adenocarcinoma , 2015, Oncotarget.